Conference
Initial results of BMS-986012, a first-in-class fucosyl-GM1 mAb, in combination with nivolumab, in pts with relapsed/refractory (rel/ref) small-cell lung cancer (SCLC)
Authors
Chu QS-C; van Herpen C; Leighl NB; Markman B; Clarke S; Juergens RA; Basciano P; Lathers D; Tannenbaum-Dvir S; Urbanska K
Volume
28
Publisher
OXFORD UNIV PRESS
Publication Date
September 1, 2017
Name of conference
42nd European-Society-for-Medical-Oncology Congress (ESMO)
Conference place
Madrid, SPAIN
Conference start date
September 8, 2017
Conference end date
September 12, 2017
Conference proceedings
ANNALS OF ONCOLOGY
ISSN
0923-7534